Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-28T02:46:36.615Z Has data issue: false hasContentIssue false
  • English
  • Français

Le JCMU et les publicités pharmaceutiques : il est temps d’en finir

Published online by Cambridge University Press:  21 May 2015

Joel Lexchin
Joel Lexchin*
Affiliation:
faculté des politiques et de la gestion de la santé, Université York, Toronto (Ontario); attaché au service d'urgence, Réseau universitaire de santé, Toronto (Ontario); département de médecine familiale et communautaire, Université de Toronto, Toronto (Ontario)
*
École des politiques et gestion de la santé, Université York, 4700, rue Keele, Toronto ON M3J 1P3; jlexchin@yorku.ca

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Publicité dans les revuesindustrie pharmaceutiqueordonnancesrevenus
Type
Éditorial
Information
Canadian Journal of Emergency Medicine , Volume 11 , Issue 4 , July 2009 , pp. 380 - 384
Copyright
Copyright © Canadian Association of Emergency Physicians 2009

References

RÉFÉRENCES

1. Wilkes, MS, Doblin, BH, Shapiro, MF. Pharmaceutical advertisements in leading medical journals: experts’ assessments. Ann Intern Med 1992;116:912–9.CrossRefGoogle ScholarPubMed
2. Cooper, RJ, Schriger, DL, Wallace, RC, et al. Graphics in pharmaceutical advertisements: Are they truthful, are they adequately detailed? Plenary session at the Fourth International Congress on Peer Review in Biomedical Publication; 2001 Sep. 14–16; Barcelona (Spain): JAMA and BMJ Publishing Group; 2001. Available: http://www.ama-assn.org/public/peer/prc_program2001.htm#truthful (accessed 2009 May 15).Google Scholar
3. Lexchin, J. How patient outcomes are reported in drug advertisements: review of Canadian medical journals. Can Fam Physician 1999;45:1213–6.Google Scholar
4. Loke, TW, Koh, FC, Ward, JE. Pharmaceutical advertisement claims in Australian medical publications: Is evidence accessible, compelling and communicated comprehensively? Med J Aust 2002;177:291–3.CrossRefGoogle Scholar
5. Gutknecht, DR. Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract 2001;14:197–200.Google ScholarPubMed
6. Lankinen, KS, Levola, T, Marttinen, K, et al. Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals. Pharmacoepidemiol Drug Saf 2004;13: 789–95.CrossRefGoogle ScholarPubMed
7. Neumann, PJ, Bambauer, KZ, Ramakrishnan, V, et al. Economic messages in prescription drug advertisements in medical journals. Med Care 2002;40:840–5.CrossRefGoogle ScholarPubMed
8. Spielmans, GI, Thielges, SA, Dent, AL, et al. The accuracy of psychiatric medication advertisements in medical journals. J Nerv Ment Dis 2008;196:267–73.CrossRefGoogle ScholarPubMed
9. Montgomery, BD, Mansfield, PR, Spurling, GK, et al. Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study. BMC Public Health 2008;8:167.CrossRefGoogle ScholarPubMed
10. Cooper, RJ, Schriger, DL. The availability of references and the sponsorship of original research cited in pharmaceutical advertisements. CMAJ 2005;172:487–91.CrossRefGoogle ScholarPubMed
11. Lexchin, J, Holbrook, A. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. CMAJ 1994;151:47–54.Google Scholar
12. Hemeryck, L, Chan, R, McCormack, PME, et al. Pharmaceutical advertisements in Irish medical journals. J Pharm Med. 1995;5:147–51.Google Scholar
13. McGettigan, P, Golden, J, Fryer, J, et al. Prescribers prefer people: the sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol 2001;51:184–9.CrossRefGoogle Scholar
14. Prosser, H, Almond, S, Walley, T. Influences on GPs’ decision to prescribe new drugs — the importance of who says what. Fam Pract 2003;20:61–8.CrossRefGoogle Scholar
15. Avorn, J, Chen, M, Hartley, R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982;73:4–8.CrossRefGoogle ScholarPubMed
16. Greenwood, J. Pharmaceutical representatives and the prescribing of drugs by family doctors [dissertation]. Nottingham (UK): Nottingham University; 1989.Google Scholar
17. Findlay, S. Prescription drugs and mass media advertising. Washington (DC): National Institute for Health Care Management Research and Educational Foundation; 2000.Google Scholar
18. Bower, AD, Burkett, GL. Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes and practices. J Fam Pract 1987;24:612–6.Google ScholarPubMed
19. Ferry, ME, Lamy, PP, Becker, LA. Physicians’ knowledge of prescribing for the elderly: a study of primary care physicians in Pennsylvania. J Am Geriatr Soc 1985;33:616–21.CrossRefGoogle ScholarPubMed
20. Fletcher, RH. Adverts in medical journals: caveat lector. Lancet 2003;361:10–1.CrossRefGoogle ScholarPubMed
21. Smith, R. Should medical journals carry drug advertising? BMJ 2007;335:74.CrossRefGoogle ScholarPubMed
22. Glassman, PA, Hunter-Hayes, J, Nakamura, T. Pharmaceutical advertising revenue and physician organizations: How much is too much? West J Med 1999;171:234–8.Google ScholarPubMed
23. Fugh-Berman, A, Alladin, K, Chow, J. Advertising in medical journals: Should current practices change? PLoS Med 2006;3:e130.Google ScholarPubMed
24. Conseil consultatif de publicité pharmaceutique. Code d'agrément de la publicité. Pickering (ON): le Conseil; 2007.Google Scholar
25. Lexchin, J, Light, D. Commercial influence and the content of medical journals. BMJ 2006;332:1444–7.CrossRefGoogle ScholarPubMed
26. Mansfield, PR, Lexchin, J, Wen, LS, et al. Educating health professionals about drug and device promotion: advocates’ recommendations. PLoS Med 2006;3:e451.CrossRefGoogle ScholarPubMed
27. Hardin, G. The tragedy of the commons. Science 1968;162:1243–8.CrossRefGoogle ScholarPubMed